Shenzhen - Delayed Quote • CNY
Guizhou Xinbang Pharmaceutical Co., Ltd. (002390.SZ)
At close: April 19 at 3:04 PM GMT+8
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Ms. Yajun Xiao | CFO & Deputy GM | -- | -- | 1973 |
| Ms. Yafang Lu | Deputy General Manager | -- | -- | 1969 |
| Ms. Chuan Chen | Deputy GM & Secretary of the Board of Directors | -- | -- | 1969 |
| Mr. Pei Yang | Deputy General Manager | -- | -- | 1976 |
| Mr. Zhangjie Qing | Deputy General Manager | -- | -- | 1975 |
| Mr. Wenlin Gao | Deputy General Manager | -- | -- | 1982 |
Guizhou Xinbang Pharmaceutical Co., Ltd.
No. 1 Garden, Kekai, No. 83
North Section of Xintian Avenue Wudang District
Guiyang, 550018
China
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 5,149
Description
Guizhou Xinbang Pharmaceutical Co., Ltd. researches, develops, manufactures, and sells Chinese herbal medicines and other pharmaceutical products in China and internationally. The company offers cardiovascular and cerebrovascular, digestive system, endocrine, tumor and immune regulation, blood system, rheumatism and rheumatoid, urinary system, antipyretic analgesic, cold medicine, gynecological treatment, and anti-infective drugs. It also operates in medical services; and pharmaceutical circulation business. The company was founded in 1995 and is headquartered in Guiyang, China.
Corporate Governance
Guizhou Xinbang Pharmaceutical Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Recent Events
- May 30, 2023Ex-Dividend Date
Upcoming Events
Upcoming Events Information Not Available